COVID-19 vaccines: factors contributing to a ‘fast-track’ development

Domenica Sardone, Regulatory Program Associate Director, Roche Ltd. The COVID-19 pandemic has demanded a new global approach to vaccine development. There has been unprecedented international attention, cooperation and especially use of resources, enabling pharmaceutical companies and governmental bodies to act at speed in the interest of public health. During this challenging times and considering the

Interview with Magdalini Theodoridou, Civil Engineer and PhD in Conservation Science

I was born and raised in Greece. I hold a PhD in Conservation Science from the University of Bologna in Italy and diploma in Civil Engineering (5-year studies) from the Aristotle University of Thessaloniki in Greece. I have worked as a research and teaching fellow in Italy, Hungary and Cyprus, with scientific contributions to the design

COVID-19 pandemic: the European panorama. Focus in Italy and Spain.

by Laura Moro, Ph.D. Coronavirus disease 2019 (COVID-19) continues to escalate worldwide, with Europe and the USA being the current epicentres of the pandemic. As of April 22, there are around 2,471,000 declared cases and over 169,000 deaths globally, with many countries undergoing community transmission. The situation in Europe is particularly gloomy with over 1.2